HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 32.885

Change

+0.01 (+0.02)%

Market Cap

USD 0.15B

Volume

322.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.11 (-0.59%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.27 (+0.46%)

USD 37.29B
DFAC Dimensional U.S. Core Equity 2..

+0.16 (+0.45%)

USD 32.64B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 30.12B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 28.05B
DTB DTE Energy Company 2020 Series

-0.04 (-0.21%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.80 (-0.97%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 16.68B
AVUV Avantis® U.S. Small Cap Value..

+0.15 (+0.15%)

USD 15.39B
DFUS Dimensional U.S. Equity ETF

+0.36 (+0.54%)

USD 12.89B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.32% 65% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.32% 65% D 62% D
Trailing 12 Months  
Capital Gain 12.54% 59% D- 61% D-
Dividend Return 1.33% 29% F 21% F
Total Return 13.87% 57% F 56% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.56% 58% F 45% F
Dividend Return 4.43% 57% F 41% F
Total Return 0.88% 44% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 8.44% 60% D- 83% B
Risk Adjusted Return 52.49% 61% D- 66% D+
Market Capitalization 0.15B 68% D+ 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.